Rating History for Enliven Therapeutics (ELVN) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/2/2026 Sean Laaman New Coverage Overweight
(N/A)		 70.00
(N/A)		 45.84
(41.52)		 -9.42% Details